TrialCancer immunology, immunotherapy : CII2011

Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma.

Hirohito Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.